135 related articles for article (PubMed ID: 36271584)
1. Si-Wu-Tang ameliorates bile duct ligation-induced liver fibrosis via modulating immune environment.
Ma Z; Xue X; Bai J; Cai Y; Jin X; Jia K; Ding M; Lyu X; Li X
Biomed Pharmacother; 2022 Nov; 155():113834. PubMed ID: 36271584
[TBL] [Abstract][Full Text] [Related]
2. Si-Wu-Tang attenuates liver fibrosis via regulating lncRNA H19-dependent pathways involving cytoskeleton remodeling and ECM deposition.
Qu J; Xue X; Wang Z; Ma Z; Jia K; Li F; Zhang Y; Wu R; Zhou F; Zhao P; Li X
Chin J Nat Med; 2024 Jan; 22(1):31-46. PubMed ID: 38278557
[TBL] [Abstract][Full Text] [Related]
3. Si-Wu-Tang ameliorates fibrotic liver injury via modulating intestinal microbiota and bile acid homeostasis.
Xue X; Wu J; Ding M; Gao F; Zhou F; Xu B; Lu M; Li J; Li X
Chin Med; 2021 Nov; 16(1):112. PubMed ID: 34736501
[TBL] [Abstract][Full Text] [Related]
4. Si-Wu-Tang attenuates hepatocyte PANoptosis and M1 polarization of macrophages in non-alcoholic fatty liver disease by influencing the intercellular transfer of mtDNA.
Ma Z; Xie K; Xue X; Li J; Yang Y; Wu J; Li Y; Li X
J Ethnopharmacol; 2024 Jun; 328():118057. PubMed ID: 38518965
[TBL] [Abstract][Full Text] [Related]
5. Piperlongumine attenuates bile duct ligation-induced liver fibrosis in mice via inhibition of TGF-β1/Smad and EMT pathways.
Chilvery S; Bansod S; Saifi MA; Godugu C
Int Immunopharmacol; 2020 Nov; 88():106909. PubMed ID: 32882664
[TBL] [Abstract][Full Text] [Related]
6. Increased Expression of S100B and RAGE in a Mouse Model of Bile Duct Ligation-induced Liver Fibrosis.
Park JW; Kim MJ; Kim SE; Kim HJ; Jeon YC; Shin HY; Park SJ; Jang MK; Kim DJ; Park CK; Choi EK
J Korean Med Sci; 2021 Apr; 36(14):e90. PubMed ID: 33847081
[TBL] [Abstract][Full Text] [Related]
7. Herb medicine Yin-Chen-Hao-Tang ameliorates hepatic fibrosis in bile duct ligation rats.
Lee TY; Chang HH; Chen JH; Hsueh ML; Kuo JJ
J Ethnopharmacol; 2007 Jan; 109(2):318-24. PubMed ID: 16989967
[TBL] [Abstract][Full Text] [Related]
8. Effects and mechanisms of Xiaochaihu Tang against liver fibrosis: An integration of network pharmacology, molecular docking and experimental validation.
Wang SJ; Ye W; Li WY; Tian W; Zhang M; Sun Y; Feng YD; Liu CX; Liu SY; Cao W; Meng JR; Li XQ
J Ethnopharmacol; 2023 Mar; 303():116053. PubMed ID: 36529247
[TBL] [Abstract][Full Text] [Related]
9. Si-Wu-Tang alleviates metabolic dysfunction-associated fatty liver disease by inhibiting ACSL4-mediated arachidonic acid metabolism and ferroptosis in MCD diet-fed mice.
Xue X; Wang L; Wu R; Li Y; Liu R; Ma Z; Jia K; Zhang Y; Li X
Chin Med; 2024 Jun; 19(1):79. PubMed ID: 38844978
[TBL] [Abstract][Full Text] [Related]
10. Synergistic Hepatoprotective Effects of Mesenchymal Stem Cells and Platelet-Rich Plasma in a Rat Model of Bile Duct Ligation-Induced Liver Cirrhosis.
Shivaramu S; Maiti SK; Banu SA; Kalaiselvan E; Sharun K; Mishra M; Mohan D; Palakkara S; Kumar S; Sahoo M; Hescheler J
Cells; 2024 Feb; 13(5):. PubMed ID: 38474368
[TBL] [Abstract][Full Text] [Related]
11. The Salvia miltiorrhiza monomer IH764-3 induces apoptosis of hepatic stellate cells in vivo in a bile duct ligation-induced model of liver fibrosis.
Liu L; Wei J; Huo X; Fang S; Yao D; Gao J; Jiang H; Zhang X
Mol Med Rep; 2012 Dec; 6(6):1231-8. PubMed ID: 22971838
[TBL] [Abstract][Full Text] [Related]
12. AMPK agonist AICAR ameliorates portal hypertension and liver cirrhosis via NO pathway in the BDL rat model.
Hu L; Su L; Dong Z; Wu Y; Lv Y; George J; Wang J
J Mol Med (Berl); 2019 Mar; 97(3):423-434. PubMed ID: 30721324
[TBL] [Abstract][Full Text] [Related]
13. Cytotherapy with M1-polarized macrophages ameliorates liver fibrosis by modulating immune microenvironment in mice.
Ma PF; Gao CC; Yi J; Zhao JL; Liang SQ; Zhao Y; Ye YC; Bai J; Zheng QJ; Dou KF; Han H; Qin HY
J Hepatol; 2017 Oct; 67(4):770-779. PubMed ID: 28596109
[TBL] [Abstract][Full Text] [Related]
14. Aldehyde dehydrogenase-2 activation by Alda-1 decreases necrosis and fibrosis after bile duct ligation in mice.
Wimborne HJ; Takemoto K; Woster PM; Rockey DC; Lemasters JJ; Zhong Z
Free Radic Biol Med; 2019 Dec; 145():136-145. PubMed ID: 31557514
[TBL] [Abstract][Full Text] [Related]
15. Astragaloside prevents BDL-induced liver fibrosis through inhibition of notch signaling activation.
Yongping M; Zhang X; Xuewei L; Fan W; Chen J; Zhang H; Chen G; Liu C; Liu P
J Ethnopharmacol; 2015 Jul; 169():200-9. PubMed ID: 25917841
[TBL] [Abstract][Full Text] [Related]
16. [Mechanism of Astragaloside prevents cholestatic liver fibrosis through inhibition of Notch signaling activation].
Mu YP; Zhang X; Fan WW; Li XW; Chen GF; Chen JM; Zhang H; Liu P
Zhonghua Gan Zang Bing Za Zhi; 2017 Aug; 25(8):575-582. PubMed ID: 29056006
[No Abstract] [Full Text] [Related]
17. Melatonin ameliorates liver fibrosis induced by bile-duct ligation in rats.
Tahan G; Akin H; Aydogan F; Ramadan SS; Yapicier O; Tarcin O; Uzun H; Tahan V; Zengin K
Can J Surg; 2010 Oct; 53(5):313-8. PubMed ID: 20858375
[TBL] [Abstract][Full Text] [Related]
18. Virtual screening of the multi-gene regulatory molecular mechanism of Si-Wu-tang against non-triple-negative breast cancer based on network pharmacology combined with experimental validation.
Zhang Z; Liu J; Liu Y; Shi D; He Y; Zhao P
J Ethnopharmacol; 2021 Apr; 269():113696. PubMed ID: 33358854
[TBL] [Abstract][Full Text] [Related]
19. β-catenin/TCF4 inhibitors ICG-001 and LF3 alleviate BDL-induced liver fibrosis by suppressing LECT2 signaling.
Gao Y; Fan S; Zhao P; Li H; Cai C; Li X; Zhou Y; Huang M; Bi H
Chem Biol Interact; 2023 Feb; 371():110350. PubMed ID: 36639009
[TBL] [Abstract][Full Text] [Related]
20. Effect of tetrandrine on experimental hepatic fibrosis induced by bile duct ligation and scission in rats.
Park PH; Nan JX; Park EJ; Kang HC; Kim JY; Ko G; Sohn DH
Pharmacol Toxicol; 2000 Dec; 87(6):261-8. PubMed ID: 11140824
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
